Education
About Us
Working with TipRanks
Follow Us
Theranexus SA (FR:ALTHX)
:ALTHX
ALTHX Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.46 - €1.30
Previous CloseN/A
Volume1.58K
Average Volume (3M)42.87K
Market Cap
€3.71M
Enterprise Value€7.56M
Total Cash (Recent Filing)€7.15M
Total Debt (Recent Filing)€3.47M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Apr 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding7,758,724
10 Day Avg. Volume21,726
30 Day Avg. Volume42,869
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Theranexus SA News
PremiumCompany Announcements
Theranexus Reports Semi-Annual Liquidity Contract Update
PremiumCompany Announcements
Theranexus Announces 2025 Financial Communication Agenda
PremiumCompany Announcements
Theranexus Announces Share and Voting Rights Information
PremiumCompany Announcements
Theranexus Strengthens Financial Outlook with New Agreements
PremiumCompany Announcements
Theranexus Reports Promising Trial Results for Batten-1
PremiumCompany Announcements
Theranexus Updates Cash Position and Strategic Focus---
ALTHX FAQ
What was Theranexus SA’s price range in the past 12 months?
Theranexus SA lowest stock price was €0.46 and its highest was €1.30 in the past 12 months.
What is Theranexus SA’s market cap?
Theranexus SA’s market cap is €3.71M.
When is Theranexus SA’s upcoming earnings report date?
Theranexus SA’s upcoming earnings report date is Apr 28, 2025 which is in 46 days.
How were Theranexus SA’s earnings last quarter?
Theranexus SA released its earnings results on Sep 26, 2024. The company reported €0.013 earnings per share for the quarter, beating the consensus estimate of N/A by €0.013.
Is Theranexus SA overvalued?
According to Wall Street analysts Theranexus SA’s price is currently Overvalued.
Does Theranexus SA pay dividends?
Theranexus SA does not currently pay dividends.
What is Theranexus SA’s EPS estimate?
Theranexus SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theranexus SA have?
Theranexus SA has 7,758,724 shares outstanding.
What happened to Theranexus SA’s price movement after its last earnings report?
Theranexus SA reported an EPS of €0.013 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.068%.
Which hedge fund is a major shareholder of Theranexus SA?
Currently, no hedge funds are holding shares in FR:ALTHX
---
Company Description
Theranexus SA
Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.
---
Technical Analysis
---